Bile Duct Cancer clinical trials
Showing 51–71 of 71 active trials. Describe your situation to see which ones you may be eligible for.
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Targeted Navigation in Hepatocellular Carcinoma (HCC)
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Defining the Ablative Dose for Y-90 TARE
- Fibrinogen in Liver Transplant
- [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
- Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples
- Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
- Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
- Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
- High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.